Visit https://www.peervoice.com/XQB860 to view the entire programme with slides. After completing “Evolving the Treatment Paradigm in Metastatic HER2-Positive Breast Cancer: The Ongoing Story of Emerging Treatments”, participants will be able to: Summarise unmet needs in the management of metastatic human epidermal growth factor receptor 2 (HER2)-positive breast cancer; Explain the rationale for novel pathways and mechanism of actions for treating advanced metastatic HER2-positive breast cancer; Analyse data from clinical trials, evaluating the efficacy and safety of novel HER2-targeted therapies.